Elicio Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Elicio Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q2 2024.
  • Elicio Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -157 %, a 118% decline year-over-year.
  • Elicio Therapeutics, Inc. annual Return On Assets for 2023 was -102 %, a 114% decline from 2022.
  • Elicio Therapeutics, Inc. annual Return On Assets for 2022 was -47.8 %, a 3.13% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -157 -85.2 -118% Apr 1, 2024 Jun 30, 2024
Q1 2024 -130 -70.4 -118% Jan 1, 2024 Mar 31, 2024
Q4 2023 -102 -54.6 -114% Oct 1, 2023 Dec 31, 2023
Q3 2023 -98.9 -90.3 -1049% Jul 1, 2023 Sep 30, 2023
Q2 2023 -72.1 -55.2 -326% Apr 1, 2023 Jun 30, 2023
Q1 2023 -59.4 -35.2 -146% Jan 1, 2023 Mar 31, 2023
Q4 2022 -47.8 -1.45 -3.13% Oct 1, 2022 Dec 31, 2022
Q3 2022 -8.61 +84.6 +90.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -16.9 Apr 1, 2022 Jun 30, 2022
Q1 2022 -24.2 Jan 1, 2022 Mar 31, 2022
Q4 2021 -46.4 Oct 1, 2021 Dec 31, 2021
Q3 2021 -93.3 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.